Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

1.8K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Determination of calcium and magnesium in human hair by non-complete digestion-flame atomic absorption spectrometry].

Guang pu xue yu guang pu fen xi = Guang pu·2003
Same author

[Effects of high dose of dynorphin on NMDA receptor and NOS activities in spinal cord of rats].

Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae·2003
Same author

Effects of XW630 on bone formation in ovariectomized rats and in human osteoblast-like cells.

Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih·2003
Same author

Multiple defects of cell cycle checkpoints in U937-ASPI3K, an U937 cell mutant stably expressing anti-sense ATM gene cDNA.

Journal of Tongji Medical University = Tong ji yi ke da xue xue bao·2003
Same author

[Histological study of the local-regional invasion of pyriform sinus carcinoma].

Zhonghua er bi yan hou ke za zhi·2003
Same author

[The experimental treatment of laryngeal carcinoma with all-trans retinoic acid].

Zhonghua er bi yan hou ke za zhi·2003
Same journal

Association of systemic lupus erythematosus with 90-day readmission following heart failure hospitalization: A national readmission database (NRD) analysis, 2016-2017.

Lupus·2026
Same journal

Association of GPX4 rs713041 and rs4807542 polymorphisms and serum GPX4 levels in Chinese patients with systemic lupus erythematosus.

Lupus·2026
Same journal

Giant cell myocarditis in an 18-year-old patient with new-onset systemic lupus erythematosus: A fatal case of rapidly progressing heart failure.

Lupus·2026
Same journal

An evidence-based specialist nursing protocol for children with hypoprothrombinemia-lupus anticoagulant syndrome (HLAS) and its application research.

Lupus·2026
Same journal

T-bet expression in B cell subsets: Association with T peripheral helper cells and clinical activity in systemic lupus erythematosus.

Lupus·2026
Same journal

Autonomic dysfunction in systemic lupus erythematosus and systemic sclerosis.

Lupus·2026
See all related articles

Related Experiment Video

Updated: Feb 28, 2026

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

986

Stem cell transplantation: progress in Asia.

L Sun1

  • 1Department of Rheumatology and Immunology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, People's Republic of China. liangjunlzk@hotmail.com

Lupus
|October 16, 2010
PubMed
Summary
This summary is machine-generated.

Systemic lupus erythematosus (SLE) treatments are evolving. While immunosuppressants improved survival, new stem cell transplant therapies, including hematopoietic and mesenchymal stem cells, offer alternative approaches for managing this complex autoimmune disease.

More Related Videos

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
03:40

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

1.9K
Stem Cell Transplantation in an in vitro Simulated Ischemia/Reperfusion Model
09:15

Stem Cell Transplantation in an in vitro Simulated Ischemia/Reperfusion Model

Published on: November 5, 2011

14.5K

Related Experiment Videos

Last Updated: Feb 28, 2026

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

986
Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
03:40

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

1.9K
Stem Cell Transplantation in an in vitro Simulated Ischemia/Reperfusion Model
09:15

Stem Cell Transplantation in an in vitro Simulated Ischemia/Reperfusion Model

Published on: November 5, 2011

14.5K

Area of Science:

  • Immunology
  • Rheumatology
  • Transplantation Medicine

Background:

  • Systemic lupus erythematosus (SLE) is a severe autoimmune condition affecting multiple organs.
  • While immunosuppressive therapies have reduced mortality, some patients still face significant risks.
  • A paradigm shift in SLE treatment is necessary to address persistent mortality.

Purpose of the Study:

  • To review and compare emerging stem cell transplant strategies for Systemic lupus erythematosus.
  • To highlight the differences between allogeneic/autologous hematopoietic stem cells and mesenchymal stem cells in SLE treatment.

Main Methods:

  • Literature review of stem cell transplantation in SLE.
  • Comparative analysis of hematopoietic stem cell transplantation (HSCT) and mesenchymal stem cell (MSC) therapy.

Main Results:

  • Hematopoietic stem cell transplantation (allogeneic and autologous) has been utilized for SLE treatment.
  • Mesenchymal stem cells represent a newer, emerging therapeutic option for SLE.
  • Key procedural and outcome differences exist between HSCT and MSC therapies for SLE.

Conclusions:

  • Stem cell transplantation, particularly HSCT and MSCs, offers promising avenues for managing refractory Systemic lupus erythematosus.
  • Understanding the distinctions between these stem cell approaches is crucial for optimizing SLE patient care and improving outcomes.